DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Patent 6,384,020 protects ADDERALL 10, ADDERALL 12.5, ADDERALL 15, ADDERALL 20, ADDERALL 30, ADDERALL 5, and ADDERALL 7.5, and is included in one NDA.
Protection for ADDERALL 10 has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has six patent family members in six countries.
Summary for Patent: 6,384,020
|Title:||Rapid immediate release oral dosage form|
|Abstract:||A pharmaceutical composition comprising lactitol and one or more amphetamine salts in a rapid release formulation.|
|Inventor(s):||Flanner; Henry H. (Montgomery Village, MD), Chang; Rong-Kun (Rockville, MD), Pinkett; Jill E. (Baltimore, MD), Wassink; Sandra E. (Frederick, MD), White; Lisa R. (Damascus, MD)|
|Assignee:||Shire Laboratories, Inc. (Rockville, MD)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form;|
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||1202739||Start Trial|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|